{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:32:30Z","timestamp":1790040750608,"version":"4.0.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Isaac Dreyfus-Bernheim Stiftung"},{"DOI":"10.13039\/501100008473","name":"Gebauer Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010801","name":"Ernst G\u00f6hner Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1093\/ehjcvp\/pvz067","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T21:21:13Z","timestamp":1572556873000},"page":"199-200","source":"Crossref","is-referenced-by-count":11,"title":["Vascular Ehlers\u2013Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-7378","authenticated-orcid":false,"given":"Maria C","family":"Gorosabel","sequence":"first","affiliation":[{"name":"Center for Cardiovascular Genetics and Gene Diagnostics, Foundation for People with Rare Diseases, Wagistrasse 25, Schlieren, Zurich 8952, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo","family":"Dubacher","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Genetics and Gene Diagnostics, Foundation for People with Rare Diseases, Wagistrasse 25, Schlieren, Zurich 8952, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Meienberg","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Genetics and Gene Diagnostics, Foundation for People with Rare Diseases, Wagistrasse 25, Schlieren, Zurich 8952, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3212-9963","authenticated-orcid":false,"given":"Gabor","family":"Matyas","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Genetics and Gene Diagnostics, Foundation for People with Rare Diseases, Wagistrasse 25, Schlieren, Zurich 8952, Switzerland"},{"name":"Zurich Center for Integrative Human Physiology, University of Zurich, Winterthurerstrasse 190, Zurich 8057, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"2020090710535968400_pvz067-B1","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvz095","article-title":"Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers-Danlos syndrome","author":"Dubacher","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2020090710535968400_pvz067-B2","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0140-6736(10)60960-9","article-title":"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomized, open, blinded-endpoints trial","volume":"376","author":"Ong","year":"2010","journal-title":"Lancet"},{"key":"2020090710535968400_pvz067-B3","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.jacc.2019.01.058","article-title":"Vascular Ehlers-Danlos syndrome: long-term observational study","volume":"73","author":"Frank","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2020090710535968400_pvz067-B4","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jacc.2019.02.025","article-title":"Vascular Ehlers-Danlos syndrome management: the paris way, a step forward on a long road","volume":"73","author":"De Backer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2020090710535968400_pvz067-B5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.CIR.0000137831.08683.E1","article-title":"Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice","volume":"110","author":"Liao","year":"2004","journal-title":"Circulation"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvz067\/31063070\/pvz067.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/6\/3\/199\/33722731\/pvz067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/6\/3\/199\/33722731\/pvz067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T14:54:12Z","timestamp":1599490452000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/6\/3\/199\/5613805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":5,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,11,6]]},"published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvz067","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2019,11,6]]}}}